Mosaic ImmunoEngineering Files Q1 2025 10-Q

Ticker: CPMV · Form: 10-Q · Filed: May 20, 2025 · CIK: 836564

Mosaic Immunoengineering INC. 10-Q Filing Summary
FieldDetail
CompanyMosaic Immunoengineering INC. (CPMV)
Form Type10-Q
Filed DateMay 20, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, biotech

TL;DR

Mosaic ImmunoEngineering filed its Q1 2025 10-Q. All systems go.

AI Summary

Mosaic ImmunoEngineering Inc. filed its 10-Q for the period ending March 31, 2025. The company, previously known as Patriot Scientific Corp and Patriot Financial Corp, is in the biological products sector. Its fiscal year ends on December 31st, and its principal executive offices are located in Huntington Beach, California.

Why It Matters

This filing provides investors with an update on Mosaic ImmunoEngineering's financial performance and operational status for the first quarter of 2025.

Risk Assessment

Risk Level: low — This is a standard quarterly filing with no immediate red flags or significant new disclosures.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Mosaic ImmunoEngineering Inc.?

Mosaic ImmunoEngineering Inc. is in the business of Biological Products (No Diagnostic Substances), SIC code 2836.

When was the company formerly known as Patriot Scientific Corp?

The company's name was changed from Patriot Scientific Corp on July 3, 1992.

What is the physical address of Mosaic ImmunoEngineering Inc.?

The company's business and mailing address is 9114 Adams Ave., #202, Huntington Beach, CA 92646.

What is the SEC file number for Mosaic ImmunoEngineering Inc.?

The SEC file number for Mosaic ImmunoEngineering Inc. is 000-22182.

What is the reporting period for this 10-Q filing?

This 10-Q filing is for the period ending March 31, 2025.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 20, 2025 regarding Mosaic ImmunoEngineering Inc. (CPMV).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing